{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:47:54Z","timestamp":1785552474817,"version":"3.56.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1124\/mol.119.118042","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T13:19:26Z","timestamp":1582291166000},"page":"287-294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Structures of Mycobacterium tuberculosis Penicillin-Binding Protein 3 in Complex with Five \u03b2-Lactam Antibiotics Reveal Mechanism of Inactivation"],"prefix":"10.1016","volume":"97","author":[{"given":"Zuokun","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Guddat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Schofield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihe","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.119.118042_bib1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1124\/mol.119.118042_bib2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1107\/S0907444912001308","article-title":"Towards automated crystallographic structure refinement with phenix.refine","volume":"68","author":"Afonine","year":"2012","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1124\/mol.119.118042_bib3","doi-asserted-by":"crossref","first-page":"12406","DOI":"10.1038\/ncomms12406","article-title":"Structural basis of metallo-\u03b2-lactamase, serine-\u03b2-lactamase and penicillin-binding protein inhibition by cyclic boronates","volume":"7","author":"Brem","year":"2016","journal-title":"Nat Commun"},{"key":"10.1124\/mol.119.118042_bib4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2165\/00003495-198631020-00002","article-title":"Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use","volume":"31","author":"Brogden","year":"1986","journal-title":"Drugs"},{"key":"10.1124\/mol.119.118042_bib5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fmicb.2013.00096","article-title":"A brief multi-disciplinary review on antimicrobial resistance in medicine and its linkage to the global environmental microbiota","volume":"4","author":"Cantas","year":"2013","journal-title":"Front Microbiol"},{"key":"10.1124\/mol.119.118042_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1124\/mol.119.118042_bib8","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/j.1365-2958.2006.05491.x","article-title":"Interaction between FtsW and penicillin-binding protein 3 (PBP3) directs PBP3 to mid-cell, controls cell septation and mediates the formation of a trimeric complex involving FtsZ, FtsW and PBP3 in mycobacteria","volume":"62","author":"Datta","year":"2006","journal-title":"Mol Microbiol"},{"issue":"1","key":"10.1124\/mol.119.118042_bib9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijmyco.2014.10.018","article-title":"Meropenem-clavulanate has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis","volume":"4","author":"Davies Forsman","year":"2015","journal-title":"Int J Mycobacteriol"},{"key":"10.1124\/mol.119.118042_bib10","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1128\/AAC.03461-14","article-title":"Rapid cytolysis of Mycobacterium tuberculosis by faropenem, an orally bioavailable \u03b2-lactam antibiotic","volume":"59","author":"Dhar","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/mol.119.118042_bib11","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1124\/mol.119.118042_bib12","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1124\/mol.119.118042_bib13","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1128\/AAC.05690-11","article-title":"Meropenem-clavulanic acid shows activity against Mycobacterium tuberculosis in vivo","volume":"56","author":"England","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/mol.119.118042_bib14","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025221","article-title":"\u03b2-lactam resistance mechanisms: gram-positive bacteria and Mycobacterium tuberculosis","volume":"6","author":"Fisher","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1124\/mol.119.118042_bib15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1099\/mic.0.27629-0","article-title":"Genetic analysis of the beta-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to beta-lactam antibiotics","volume":"151","author":"Flores","year":"2005","journal-title":"Microbiology"},{"key":"10.1124\/mol.119.118042_bib16","doi-asserted-by":"crossref","first-page":"22002","DOI":"10.1073\/pnas.1013092107","article-title":"Structural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevant strains of Pseudomonas aeruginosa","volume":"107","author":"Han","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.119.118042_bib17","doi-asserted-by":"crossref","first-page":"11998","DOI":"10.1021\/bi701506h","article-title":"Irreversible inhibition of the Mycobacterium tuberculosis beta-lactamase by clavulanate","volume":"46","author":"Hugonnet","year":"2007","journal-title":"Biochemistry"},{"key":"10.1124\/mol.119.118042_bib18","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1126\/science.1167498","article-title":"Meropenem-clavulanate is effective against extensively drug-resistant Mycobacterium tuberculosis","volume":"323","author":"Hugonnet","year":"2009","journal-title":"Science"},{"key":"10.1124\/mol.119.118042_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"XDS","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1124\/mol.119.118042_bib20","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1107\/S0907444912048998","article-title":"Structural basis for the inhibition of Mycobacterium tuberculosis L,D-transpeptidase by meropenem, a drug effective against extensively drug-resistant strains","volume":"69","author":"Kim","year":"2013","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1124\/mol.119.118042_bib21","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1128\/AAC.43.5.1170","article-title":"In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum \u03b2-lactamase-and extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolates","volume":"43","author":"Kohler","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/mol.119.118042_bib22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2958.2012.08199.x","article-title":"Meropenem inhibits D,D-carboxypeptidase activity in Mycobacterium tuberculosis","volume":"86","author":"Kumar","year":"2012","journal-title":"Mol Microbiol"},{"key":"10.1124\/mol.119.118042_bib23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nchembio.2237","article-title":"Non-classical transpeptidases yield insight into new antibacterials","volume":"13","author":"Kumar","year":"2017","journal-title":"Nat Chem Biol"},{"key":"10.1124\/mol.119.118042_bib24","doi-asserted-by":"crossref","first-page":"6977","DOI":"10.1128\/AAC.01291-16","article-title":"Bedaquiline targets the \u03b5 subunit of mycobacterial F-ATP synthase","volume":"60","author":"Kundu","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/mol.119.118042_bib25","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1002\/anie.201809424","article-title":"Non-hydrolytic \u03b2-lactam antibiotic fragmentation by l,d-transpeptidases and serine \u03b2-lactamase cysteine variants","volume":"58","author":"Lohans","year":"2019","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1124\/mol.119.118042_bib26","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J Appl Crystallogr"},{"issue":"A","key":"10.1124\/mol.119.118042_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/24.suppl_A.1","article-title":"The carbapenems: new broad spectrum beta-lactam antibiotics","volume":"24","author":"Moellering","year":"1989","journal-title":"J Antimicrob Chemother"},{"key":"10.1124\/mol.119.118042_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2958.2009.06750.x","article-title":"Novel role of Wag31 in protection of mycobacteria under oxidative stress","volume":"73","author":"Mukherjee","year":"2009","journal-title":"Mol Microbiol"},{"key":"10.1124\/mol.119.118042_bib29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1107\/S0907444911001314","article-title":"REFMAC5 for the refinement of macromolecular crystal structures","volume":"67","author":"Murshudov","year":"2011","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1124\/mol.119.118042_bib30","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1107\/S0907444996012255","article-title":"Refinement of macromolecular structures by the maximum-likelihood method","volume":"53","author":"Murshudov","year":"1997","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1124\/mol.119.118042_bib31","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1021\/ar00100a005","article-title":"The mechanisms of reactions of .beta.-lactam antibiotics","volume":"17","author":"Page","year":"1984","journal-title":"Acc Chem Res"},{"key":"10.1124\/mol.119.118042_bib32","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1128\/AAC.00296-11","article-title":"Carbapenems: past, present, and future","volume":"55","author":"Papp-Wallace","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/mol.119.118042_bib33","doi-asserted-by":"crossref","first-page":"558","DOI":"10.5588\/ijtld.11.0414","article-title":"Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosis","volume":"16","author":"Payen","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1124\/mol.119.118042_bib34","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1128\/JB.01795-14","article-title":"Mycobacterium tuberculosis MtrB sensor kinase interactions with FtsI and Wag31 proteins reveal a role for MtrB distinct from that regulating MtrA activities","volume":"196","author":"Plocinska","year":"2014","journal-title":"J Bacteriol"},{"key":"10.1124\/mol.119.118042_bib35","doi-asserted-by":"crossref","first-page":"8207","DOI":"10.1021\/acs.jmedchem.6b00448","article-title":"\u03b2-Lactamases: why and how","volume":"59","author":"Pratt","year":"2016","journal-title":"J Med Chem"},{"key":"10.1124\/mol.119.118042_bib36","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/1873-3468.12054","article-title":"Crystal structures of penicillin-binding protein 3 in complexes with azlocillin and cefoperazone in both acylated and deacylated forms","volume":"590","author":"Ren","year":"2016","journal-title":"FEBS Lett"},{"key":"10.1124\/mol.119.118042_bib37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jmb.2010.10.024","article-title":"Crystal structures of penicillin-binding protein 3 from Pseudomonas aeruginosa: comparison of native and antibiotic-bound forms","volume":"405","author":"Sainsbury","year":"2011","journal-title":"J Mol Biol"},{"key":"10.1124\/mol.119.118042_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098042","article-title":"Crystal structure of penicillin-binding protein 3 (PBP3) from Escherichia coli","volume":"9","author":"Sauvage","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/mol.119.118042_bib39","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1574-6976.2008.00105.x","article-title":"The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis","volume":"32","author":"Sauvage","year":"2008","journal-title":"FEMS Microbiol Rev"},{"key":"10.1124\/mol.119.118042_bib40","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1128\/AAC.42.6.1524","article-title":"Contribution of beta-lactamases to beta-lactam susceptibilities of susceptible and multidrug-resistant Mycobacterium tuberculosis clinical isolates","volume":"42","author":"Segura","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/mol.119.118042_bib41","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/jac\/dkn507","article-title":"Morphological features and signature gene response elicited by inactivation of FtsI in Mycobacterium tuberculosis","volume":"63","author":"Slayden","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1124\/mol.119.118042_bib42","doi-asserted-by":"crossref","first-page":"519","DOI":"10.7164\/antibiotics.43.519","article-title":"A novel carbapenem antibiotic, SM-7338 structure-activity relationships","volume":"43","author":"Sunagawa","year":"1990","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1124\/mol.119.118042_bib43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1128\/AAC.21.1.85","article-title":"Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria","volume":"21","author":"Sykes","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/mol.119.118042_bib44","doi-asserted-by":"crossref","first-page":"22777","DOI":"10.1074\/jbc.M111.239988","article-title":"Inactivation kinetics of a new target of beta-lactam antibiotics","volume":"286","author":"Triboulet","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.119.118042_bib45","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.4155\/fmc-2016-0078","article-title":"The road to avibactam: the first clinically useful non-\u03b2-lactam working somewhat like a \u03b2-lactam","volume":"8","author":"Wang","year":"2016","journal-title":"Future Med Chem"},{"key":"10.1124\/mol.119.118042_bib46","series-title":"Global Tuberculosis Report 2018","year":"2018"},{"key":"10.1124\/mol.119.118042_bib47","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1124\/mol.119.118042_bib48","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.cell.2019.01.003","article-title":"Crystal structures of membrane transporter MmpL3, an anti-TB drug target","volume":"176","author":"Zhang","year":"2019","journal-title":"Cell"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24009908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24009908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.119.118042","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:32:28Z","timestamp":1739961148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24009908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0026895X24009908"],"URL":"https:\/\/doi.org\/10.1124\/mol.119.118042","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structures of Mycobacterium tuberculosis Penicillin-Binding Protein 3 in Complex with Five \u03b2-Lactam Antibiotics Reveal Mechanism of Inactivation","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.119.118042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}